Volume 10, Number 1—January 2004
Research
Respiratory and Urinary Tract Infections, Arthritis, and Asthma Associated with HTLV-I and HTLV-II Infection
Table 4
Symptoms | HTLV seronegative (N = 799) | HTLV-I (N = 152) | HTLV-II (N = 387) | ||||
---|---|---|---|---|---|---|---|
Cases (%)b | Cases (%)b | ORc | Adj. OR (95% CI)d | Cases (%)b | ORc | Adj. OR (95% CI)d | |
Trouble walking, climbing or rising from chair | 147 (21) | 52 (42) | 2.71 | 2.67 (1.74 to 4.09) | 133 (42) | 2.78 | 3.44 (2.52 to 4.71) |
Incontinence, pre- or post-void urgency | 175 (25) | 50 (40) | 2.03 | 2.02 (1.33 to 33.07) | 134 (43) | 2.25 | 2.59 (1.92 to 3.49) |
Lymphadenopathy | 29 (4) | 11 (9) | 2.26 | 2.39 (1.14 to 5.03) | 40 (13) | 3.40 | 3.08 (1.85 to 5.13) |
Night sweats | 20 (3) | 15 (12) | 4.68 | 4.73 (2.31 to 9.69) | 47 (15) | 6.02 | 4.97 (2.77 to 8.94 |
Weight loss | 40 (6) | 9 (7) | 1.29 | 1.10 (0.51 to 2.37) | 40 (13) | 2.43 | 2.10 (1.22 to 3.60) |
Foot paresthesias | 57 (8) | 22 (18) | 2.44 | 2.46 (1.41 to 4.28 | 66 (21) | 3.02 | 3.27 (2.19 to 4.88) |
Impotence (males only) | 33 (5) | 10 (8) | 2.24 | 2.05 (0.77 to 5.49) | 13 (4) | 1.10 | 1.27 (0.56 to 2.91) |
aOnly the first diagnosis of each symptom is considered for each participant.
bDenominator for percentage calculation varied according to the number of participants included in each disease-specific analysis.
cUnadjusted.
dAdjusted. Models were adjusted for age, race and ethnicity, and duration of follow-up (all symptoms), and gender (all except impotence). In addition, specific models included community versus autologous donation (for trouble walking and incontinence, weight loss and impotence.) and injection drug use [night sweats and weight loss]).
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.